Lancet 405 , 15801593 (2025)
If you, or someone you care for, is taking GLP-1s and you notice symptoms such as severe, persistent stomach pain that may radiate to the back and may be accompanied by nausea and vomiting, then we advise you speak to a healthcare professional and report it via our yellow card scheme. Separately, the MHRA said that patients taking GLP-1s had been recruited to the Yellow Card Biobank study, a collaboration between the MHRA and Genomics England, which will investigate whether the risk of an inflamed pancreas can be influenced by an individuals genes
Severe or persistent body aches while taking Mounjaro should be reported to a healthcare professional as they may indicate the medication isn't the right fit for the individual
Dose conversion between semaglutide and tirzepatide There is no official FDA-approved conversion chart between semaglutide and tirzepatide
You must be a resident of Illinois
Oral GLP-1 drops EllieMD also offers sublingual (under the tongue) drops for both semaglutide and tirzepatide formulations
